Tenax Buys PH Precision Med, Plans Trial for Oral Imatinib
News, PAH News
Tenax Therapeutics has acquired PH Precision Med (PHPM), a private biotech focused on developing imatinib as a treatment for pulmonary arterial hypertension (PAH). “The acquisition of PHPM immediately expands ... Read more